BIOMAT Database Logo BIOMAT Database Logo

Acyclic purine phosphonate analogues as antiviral agents. Synthesis and structure-activity relationships. 1990

C U Kim, and B Y Luh, and P F Misco, and J J Bronson, and M J Hitchcock, and I Ghazzouli, and J C Martin
Bristol-Myers Squibb Company, Pharmaceutical Research and Development Division, Wallingford, Connecticut 06492.

A series of 9-(phosphonoalkyl)purines, which are analogues of 9-[2-(phosphonomethoxy)ethyl]purines (guanine, PMEG, 1; adenine, PMEA, 2), were synthesized. The analogues were tested for activity against herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), human cytomegalovirus (HCMV), Rauscher murine leukemia virus (R-MuLV), and human immunodeficiency virus type 1 (HIV-1). With variations in the length of the alkyl chain, the optimal activity was achieved with two carbons between the purine base and the phosphonomethoxy functionality. Despite the structural similarity and the close pKa2 value of 8 to that of PMEG, no phosphorylation of 8 was observed by the bovine brain guanylate kinase. Since all isosteric analogues of PMEG (7-9) were not inhibitory against HSV-1 and HSV-2, the presence of the 3'-oxygen atom in the PME purines proved critical for anti-HSV activity. Introduction of the 1'-methyl group on the PMEG side chain significantly reduced its anti-HSV activity. Analogue 11, which is a mimic of the phosphate by incorporation of the alpha,alpha-difluoro carbon, was ineffective against HSV-1 and HSV-2. These results suggest that the structural requirements of PME purines for anti-HSV activity appear to be very strict.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012190 Retroviridae Family of RNA viruses that infects birds and mammals and encodes the enzyme reverse transcriptase. The family contains seven genera: DELTARETROVIRUS; LENTIVIRUS; RETROVIRUSES TYPE B, MAMMALIAN; ALPHARETROVIRUS; GAMMARETROVIRUS; RETROVIRUSES TYPE D; and SPUMAVIRUS. A key feature of retrovirus biology is the synthesis of a DNA copy of the genome which is integrated into cellular DNA. After integration it is sometimes not expressed but maintained in a latent state (PROVIRUSES). Leukemogenic Viruses,Leukoviruses,Oncornaviruses,Oncovirinae,Oncoviruses,Oncoviruses, Type C,RNA Tumor Viruses,Retroviruses,Type C Oncoviruses,C Oncovirus, Type,C Oncoviruses, Type,Leukemogenic Virus,Leukovirus,Oncornavirus,Oncovirus,Oncovirus, Type C,RNA Tumor Virus,Retrovirus,Tumor Virus, RNA,Tumor Viruses, RNA,Type C Oncovirus,Virus, Leukemogenic,Virus, RNA Tumor,Viruses, Leukemogenic,Viruses, RNA Tumor
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical
D018139 Simplexvirus A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. The type species is HERPESVIRUS 1, HUMAN. Herpes Simplex Virus,Herpesvirus 1, Saimiriine,Herpesvirus 1, Saimirine,Herpesvirus 16, Cercopithecine,Marmoset Virus,Cercopithecine Herpesvirus 16,Herpes Labialis Virus,Herpes-T Virus,Herpesvirus 1 (alpha), Saimirine,Herpesvirus Hominis,Herpesvirus Papio 2,Herpesvirus Platyrhinae,Marmoset Herpesvirus,Saimiriine Herpesvirus 1,Herpes Labialis Viruses,Herpes Simplex Viruses,Herpes T Virus,Herpes-T Viruses,Herpesvirus Homini,Herpesvirus, Marmoset,Herpesviruses, Marmoset,Homini, Herpesvirus,Hominis, Herpesvirus,Labialis Virus, Herpes,Labialis Viruses, Herpes,Marmoset Herpesviruses,Marmoset Viruses,Platyrhinae, Herpesvirus,Saimirine Herpesvirus 1,Simplexviruses,Virus, Herpes Labialis,Viruses, Herpes Labialis
D063065 Organophosphonates Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P Phosphonate,Phosphonates,Phosphonic Acid Esters,Acid Esters, Phosphonic,Esters, Phosphonic Acid

Related Publications

C U Kim, and B Y Luh, and P F Misco, and J J Bronson, and M J Hitchcock, and I Ghazzouli, and J C Martin
Antiviral acyclic nucleoside phosphonate analogues as inhibitors of purine nucleoside phosphorylase.
January 1998, Advances in experimental medicine and biology,
C U Kim, and B Y Luh, and P F Misco, and J J Bronson, and M J Hitchcock, and I Ghazzouli, and J C Martin
Structure-Activity Relationships of Acyclic Selenopurine Nucleosides as Antiviral Agents.
July 2017, Molecules (Basel, Switzerland),
C U Kim, and B Y Luh, and P F Misco, and J J Bronson, and M J Hitchcock, and I Ghazzouli, and J C Martin
Structure-activity relationships and optimization of acyclic acylphloroglucinol analogues as novel antimicrobial agents.
January 2017, European journal of medicinal chemistry,
C U Kim, and B Y Luh, and P F Misco, and J J Bronson, and M J Hitchcock, and I Ghazzouli, and J C Martin
Novel 1,2,4-triazole and purine acyclic cyclopropane nucleoside analogues: synthesis, antiviral and cytostatic activity evaluations.
July 2011, Antiviral chemistry & chemotherapy,
C U Kim, and B Y Luh, and P F Misco, and J J Bronson, and M J Hitchcock, and I Ghazzouli, and J C Martin
Synthesis and structure-activity relationships of lansine analogues as antileishmanial agents.
November 2012, ChemMedChem,
C U Kim, and B Y Luh, and P F Misco, and J J Bronson, and M J Hitchcock, and I Ghazzouli, and J C Martin
Synthesis of acyclic 6,7-dihaloquinolone nucleoside analogues as potential antibacterial and antiviral agents.
June 2000, Bioorganic & medicinal chemistry,
C U Kim, and B Y Luh, and P F Misco, and J J Bronson, and M J Hitchcock, and I Ghazzouli, and J C Martin
Synthesis and structure-activity relationships of andrographolide analogues as novel cytotoxic agents.
September 2004, Bioorganic & medicinal chemistry letters,
C U Kim, and B Y Luh, and P F Misco, and J J Bronson, and M J Hitchcock, and I Ghazzouli, and J C Martin
Synthesis, evaluation and structure-activity relationships of triazine dimers as novel antiviral agents.
December 2012, Bioorganic & medicinal chemistry letters,
C U Kim, and B Y Luh, and P F Misco, and J J Bronson, and M J Hitchcock, and I Ghazzouli, and J C Martin
Synthesis and structure-activity relationships of novel camphecene analogues as anti-influenza agents.
December 2019, Bioorganic & medicinal chemistry letters,
C U Kim, and B Y Luh, and P F Misco, and J J Bronson, and M J Hitchcock, and I Ghazzouli, and J C Martin
Synthesis and structure-activity relationships of TAN-1511 analogues as potent hematopoietic agents.
February 1998, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!